Follow-up in Early and Locally Advanced Breast Cancer Patients

Prior treatment

• Patients on maintenance therapy (other than endocrine therapy).

Other illness

• Metastatic breast cancer (defined as secondary spread to other organs, such as bones, lung, liver, mediastinal lymph nodes) or DCIS.
• Other cancer diagnosis in the past 5 years except non-melanotic skin cancer or cervical intraepithelial neoplasia.
• Male breast cancer.
• Any psychological (including preexisting psychiatric disorders), familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.

Other

• Patients participating in interventional clinical studies with Quality of Life as primary endpoint.

• Histologically proven Early Breast Cancer (EBC) and Locally Advanced Breast Cancer (LABC) patients who have completed their primary treatment (except endocrine therapy), between 12 months and 36 months after the diagnosis.
• Disease-free without any evidence of relapse
• Age ≥ 18 years.
• Ability to understand and fill out questionnaires.
• Written informed consent.